Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
141.96
-1.25 (-0.87%)
At close: Nov 3, 2025, 4:00 PM EST
135.48
-6.48 (-4.57%)
After-hours: Nov 3, 2025, 7:41 PM EST
Neurocrine Biosciences (NBIX) Revenue by Segment
History
| Date | Ingrezza | Ongentys and Other Products | Collaboration and Other |
|---|---|---|---|
| Sep 30, 2025 | 2.47B | 19.80M | 25.90M |
| Jun 30, 2025 | 2.40B | 18.30M | 26.40M |
| Mar 31, 2025 | 2.35B | 18.20M | 27.30M |
| Dec 31, 2024 | 2.31B | 17.20M | 24.70M |
| Sep 30, 2024 | 2.20B | 18.00M | 26.20M |
| Jun 30, 2024 | 2.07B | 20.40M | 27.70M |
| Mar 31, 2024 | 1.93B | 22.70M | 27.70M |
| Dec 31, 2023 | 1.84B | 24.60M | 26.50M |
| Sep 30, 2023 | 1.74B | 23.00M | 25.90M |
| Jun 30, 2023 | 1.63B | 19.80M | 27.50M |
| Mar 31, 2023 | 1.54B | 15.60M | 47.30M |
| Dec 31, 2022 | 1.43B | 13.10M | 47.80M |
| Sep 30, 2022 | 1.33B | 10.20M | 48.90M |
| Jun 30, 2022 | 1.24B | 9.60M | 47.50M |
| Mar 31, 2022 | 1.15B | 9.20M | 43.40M |
| Dec 31, 2021 | 1.08B | 8.20M | 43.40M |
| Sep 30, 2021 | 1.02B | 6.60M | 41.50M |
| Jun 30, 2021 | 988.80M | 4.40M | 38.70M |
| Mar 31, 2021 | 991.60M | - | 51.40M |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.